Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 149.00
Bid: 148.00
Ask: 149.00
Change: -1.00 (-0.67%)
Spread: 1.00 (0.676%)
Open: 146.40
High: 149.00
Low: 146.40
Prev. Close: 150.00
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directors' Dealings - Sarah Evans

14 Jul 2017 10:51

RNS Number : 0905L
Apax Global Alpha Limited
14 July 2017
 

14 July 2017

 

(LSE: APAX)

Apax Global Alpha Limited

 

Directors' Dealings - Sarah Evans

 

This notification is made in accordance with DTR 3.1 of the Disclosure and Transparency Rules and article 19(1) of the Market Abuse Regulations (EU) no. 596/2014 ("MAR").

 

The Company was notified on 13 July 2017 that, on that date, Mrs Sarah Evans has beneficially acquired 20,000 Ordinary Shares of No Par Value in the Company at a price per share of £1.523, which are held through a nominee arrangement with Hargreaves Lansdown Nominee Limited. Following the purchase, Mrs Evans owns 20,000 Ordinary Shares, representing less than 1% of the Company's total issued share capital.

 

The Company was notified on 13 July 2017 that, on that date, Mr Huw Evans, a person closely associated to Mrs Evans (as defined under MAR) has beneficially acquired 35,000 Ordinary Shares of No Par Value in the Company at a price per share of £1.525, which are held through a nominee arrangement with Hargreaves Lansdown Nominee Limited. Following the purchase, Mr Evans owns 55,000 Ordinary Shares, representing less than 1% of the Company's total issued share capital.

 

Contact details

 

Investor and media enquiries

Sarah Wojcik

Telephone: +44 (0)20 7666 6573

Email: sarah.wojcik@apax.com

Company Secretary

Jacques Colley

Telephone: +44 (0) 1481 749 700

Email: AGA-admin@aztecgroup.co.uk

 

Notes

 

1. Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

2. Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014 ("MAR")

3. This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions.

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value (NAV).

 

The investment policy of the Company is to make private equity investments in Apax Funds and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities. The Company's portfolio is expected to be allocated in approximately equal proportions between Private Equity and Derived Investments, although the investment mix will fluctuate over time due to market conditions, investment opportunities, cash flow requirements, the dividend policy and other factors.

 

Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com

 

About Apax Partners LLP

 

Apax Partners is a leading global private equity advisory firm. It operates globally and has more than 30 years of investing experience. Apax Partners has advised funds that total over €40 billion in aggregate as at 31 March 2017*. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide longterm equity financing to build and strengthen worldclass companies. For further information about Apax Partners, please visit www.apax.com.

 

Apax Partners is authorised and regulated by the Financial Conduct Authority in the UK.

 

* Funds raised since 1981, commitments converted from fund currency to EUR at FX rates as at March 2017

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

SARAH EVANS

2

 

Reason for the notification

 

a)

 

Position/status

 

 

NON-EXECUTIVE DIRECTOR

b)

 

Initial notification /Amendment

 

 

INITIAL

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

APAX GLOBAL ALPHA LIMITED

b)

 

LEI

 

 

21380031LQE8CU8NU843

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

ORDINARY SHARES

 

 

APAX

 

b)

 

Nature of the transaction

 

 

PURCHASE

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£1.523

 

20,000

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

AS IN 4 C) ABOVE

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

13 July 2017

f)

 

Place of the transaction

 

 

LONDON STOCK EXCHANGE

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

HUW EVANS

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PERSON CLOSELY ASSOCIATED TO PDMR

b)

 

Initial notification /Amendment

 

 

INITIAL

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

APAX GLOBAL ALPHA LIMITED

b)

 

LEI

 

 

21380031LQE8CU8NU843

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

ORDINARY SHARES

 

 

APAX

 

b)

 

Nature of the transaction

 

 

PURCHASE

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

£1.525

 

35,000

 

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

 

AS IN 4 C) ABOVE

 

 

 

 

 

 

 

e)

 

Date of the transaction

 

 

13 July 2017

f)

 

Place of the transaction

 

 

LONDON STOCK EXCHANGE

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHSFISULFWSELW
Date   Source Headline
8th Mar 20167:00 amRNS2015 Annual Report and Audited Accounts
8th Mar 20167:00 amRNSFinal Results
24th Feb 20163:22 pmRNSDisclosure of Home Member State
12th Feb 20167:00 amRNSNotification of 2015 Annual Results
5th Feb 20167:00 amRNSApax Fund IX Commitment and RCF Renewal
25th Jan 20163:32 pmRNSApax Fund Valuations as at 31 December 2015
4th Nov 20157:00 amRNSQ3 2015 Market Update
19th Oct 20152:39 pmRNSApax Fund Valuations as at 30 September 2015
6th Oct 201512:24 pmRNSNotice of Q3 2015 Results
17th Sep 20153:10 pmRNSDirector/PDMR Shareholding
28th Aug 20153:10 pmRNSDirector/PDMR Shareholding
26th Aug 20157:00 amRNS2015 Interim Report and Accounts
26th Aug 20157:00 amRNS2015 Interim Highlights
22nd Jul 20157:00 amRNSAppointment of Director
17th Jul 20154:03 pmRNSApax Fund Valuations as at 30 June 2015
30th Jun 20153:32 pmRNSTotal Voting Rights
23rd Jun 20154:18 pmRNSHolding(s) in Company
22nd Jun 20153:11 pmRNSHolding(s) in Company
19th Jun 20157:00 amRNSHolding(s) in Company
19th Jun 20157:00 amRNSHolding(s) in Company
15th Jun 20158:00 amRNSAdmission to trading on the London Stock Exchange

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.